Fairvalue-Calculator Fairvalue-Calculator
EN DE

Maternus-Kliniken Aktiengesellschaft (MAK) Fair Value & Analysis

Healthcare · DE · Market cap €21.2M

Price€0.9000
Fair Value€2.28
Upside+153.3%
Quality95/100
Evidence: Medium Range €2.28 – €3.32

Fair value as of: Jun 25, 2026

Analysis

Maternus-Kliniken Aktiengesellschaft (MAK) currently trades at €0.9000, while our model-based Fair Value estimate is €2.28 — implying the stock looks roughly 153.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes in Germany. The company offers senior living and care facilities, rehabilitation clinics, and specialized services in geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, and follow-up treatment services, as well as fully inpatient care, outpatient care, and home emergency call services. Maternus-Kliniken Aktiengesellschaft was founded in 1877 and is headquartered in Berlin, Germany.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -73% Fresenius SE (FSNUY) -25% 5225 (5225) -70% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) -7% Tenet Healthcare Corporation (THC) +74%

Frequently asked questions

Is Maternus-Kliniken Aktiengesellschaft (MAK) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €2.28 versus a price of €0.9000 — about +153% (undervalued). Model-based estimate, not financial advice.
What is the fair value of MAK?
Our 21-model fair value for Maternus-Kliniken Aktiengesellschaft is €2.28 (as of Jun 25, 2026), built from audited fundamentals. The current price is €0.9000.
What is the quality score of MAK?
Maternus-Kliniken Aktiengesellschaft has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.